Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
CONCLUSION: Cut-off serum concentrations ≥5.0 µg/ml for IFX and ≥5.9 µg/ml for ADL were associated with perianal fistula closure. Hence, patients with producing perianal fistulas may benefit from anti-TNF dose intensification to achieve fistula closure.
PMID: 31032686 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Crohn's Disease | Gastroenterology | Humira | Inflammatory Bowel Disease | MRI Scan | PET Scan | Remicade